Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 530119 | NSE Symbol : | ISIN : INE444D01016 | Industry : Solvent Extraction |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
04-Feb-2025	12-Feb-2025	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve 1. Approval of the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. 2. To take on Record the Limited Review Report by the Auditors for the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. 3. Other regular matters.
28-Oct-2024	09-Nov-2024	Quarterly Results	Quarterly Results NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 ,inter alia, to consider and approve the following businesses along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the Quarter/ Half year ended 30th September,2024. 2. To take on Record the Limited Review Report by the Auditors for the Unaudited Financial Results of the Company for the Quarter/ Half year ended 30th September,2024. 3. Approval of the Un-Audited Statement of Assets and Liabilities for the Half year ended 30th September,2024; 4. Approval of the Un-Audited Statement of Cash Flow for the Half year ended 30th September,2024; and 5. Any other business. Read less.. (As Per BSE Announcement Dated on 28.10.2024) The Meeting of Board of Directors of the Company was held on Saturday, 9th day of November, 2024 at 3:00 P.M. and was concluded at 5.30 P.M. and the following decisions were taken: 1. Considered and approved the Standalone Un-audited Financial Results of the Company for the Quarter/Half year ended 30th September, 2024. 2. Taken on record the Limited Review Report of the Statutory Auditors on the Standalone Un-audited Financial Results of the Company for the Quarter/Half year ended 30th September, 2024. (As Per BSE Announcement Dated on: 09/11/2024)
02-Sep-2024	02-Sep-2024	AGM	We are pleased to inform you that the Meeting of the Board was held on 02.09.2024 at 4:00 P.M. and concluded at 7:10 P.M. at the Registered Office in which the Board has taken the following decisions:- 1. Approval for the Re-appointment of Mr. Kailash Chand Sharma (DIN: 00012900) as the CMD of the company ; 2. Approval for Appointment of Mr. Amit koserwal (DIN:06823437) as an Additional Director under the category of Non-Executive Independent Director of the Company w.e.f. 2nd September, 2024; 3. Finalization of the Annual Book Closure of the Company for the 33rd Annual General Meeting; 4. Finalization of the Cut-off Date for eligibility to participate in the Remote E-voting and E-voting at the 33rd Annual General Meeting; 5. Approval of the appointment of Scrutinizer for the E-voting process; 6. Approval of the Boards' Report, Corporate Governance Report and Notice of the 33rd Annual General Meeting.
08-Aug-2024	13-Aug-2024	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (Prohibition of Insider Trading) Regulations 2015 as may be applicable we are pleased to inform that 02/2024-25 Meeting of the Board of directors of the Company is scheduled to be held on Tuesday the 13th day of August 2024 at 3:00 P.M. at the Registered office of the company situated at Nagpur Kalan Ordinance Factory Road Itarsi (M.P.) 461111 to consider and approve the following businesses along with other routine businesses: 1. To consider and approve the Standalone Un-Audited Financial Results of the Company for the Quarter ended 30th June 2024. 2. To consider and approve the Limited Review Report by the Statutory Auditors for the Standalone Un-Audited Financial Results of the Company for the Quarter ended 30th June 2024. 3. Other Routine Business Items. We are pleased to submit Un-Audited Standalone Quarterly Financial Results for Quarter ended June 2024 alongwith the Limited Review Report. (As Per BSE Announcement Dated on: 13/08/2024)
14-May-2024	27-May-2024	Accounts	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2024. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2024. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2024 and the Statement of Profits and Loss and Cash flow Statement of change in equity and notes thereon for the year ended 31st March 2024. 4. Other Routine Business Items. Pursuant to Re. 33 of the SEBI (LODR) Regulations, 2015, we are please to submit the Financial Results along with Statement of Assets and Liabilities and Cash Flow for the quarter and year ended 31.03.2024 Read less.. Intimation of pursuant to Reg. 30 read with Clause 7 of Para A of Part A of Schedule III of the SEBI (LODR) Regulations, 2015 for change in CS and compliance Officer of the company. (As Per BSE Announcement Dated on 27.05.2024)
29-Jan-2024	10-Feb-2024	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulations 2015 and SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 6/2023-24 Meeting of the Board of Directors of the Company is scheduled to be held on Saturday the 10th day of February 2024 at 3:00 P.M. at the Registered Office of the company situated at Nagpur Kalan Ordinance Factory Road Itarsi (M.P.) 461111 to consider and approve the following businesses along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2023. 2. To take on Record the Limited Review Report by the Auditors for the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2023. 3. Other Regular matters. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are pleased to submit the Unaudited Financial Results for the Quarter/ Nine months ended 31.12.2023 along with Limited Review Report by the Auditors which were considered and approved by the Audit committee and Board of Directors at their 06/2023-24 Meeting held on 10th February, 2024 at 03:00 P.M. and Concluded at 03:40 P.M. (As per BSE Announcement Dated on 10/02/2024)
25-Oct-2023	03-Nov-2023	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve 1. Approval of the Un-Audited Financial Results of the Company for the Quarter/ Half year ended 30th September2023. 2. To take on Record the Limited Review Report by the Auditors for the Unaudited Financial Results of the Company for the Quarter/ Half year ended 30th September2023. 3. Approval of the Un-Audited Statement of Assets and Liabilities for the Half year ended 30th September2023; 4. Approval of the Un-Audited Statement of Cash Flow for the Half year ended 30th September2023; and 5. Any other business. Purpose of the meeting has been revised (As Per BSE Announcement Dated on 26/10/2023) Submission of Quarterly and Half Yearly Financial Results for the quarter and half year ended 30.09.2023. (As Per BSE Announcement Dated on 03/11/2023)
23-Aug-2023	01-Sep-2023	AGM	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2023 inter alia to consider and approve With reference to Regulation 29(1) of SEBI (LODR) Regulations 2015 as amended from time to time we are pleased to inform that the 04/2023-24 Meeting of the Board of Directors of the Company is scheduled to be held on Friday 1' September 2023 at 3:00 PM. at the Registered Office of the Company. We are pleased to inform you that the Meeting of the Board of Directors of the Company was held on Friday, 1st September, 2023 at 3:00 P.M. at the Registered Office of the Company in which the Board has taken the decisions mentioned in the SE Letter enclosed below. (As per BSE Announcement Dated on 01/09/2023)
28-Jul-2023	08-Aug-2023	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve We are pleased to inform that the 03/2023-24 Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 8thAugust 2023 at 11:00 A.M. at the Registered Office of the Company to consider and approve the following businesses along with other routine businesses: 1. Approval of the Un-Audited Quarterly Financial Results of the Company for the quarter ended 30th June 2023. 2. To take on record the Limited Review Report by the Auditors for the Financial Results of the Company for the quarter ended 30th June 2023. 3. Other Routine Businesses. We are pleased to submit the Unaudited Standalone Quarterly Financial Results for the quarter ended June 2023 alongwith the Limited Review Report. (As Per BSE Announcement dated on 08.08.2023)
16-May-2023	30-May-2023	Accounts	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve 1. To consider & approve the Standalone Audited financial results of the Company for the Quarter/Year ended 31st March 2023. 2. To take on record the Audit Report of the Statutory Auditors for the Standalone Audited Financial Results of the Company for the Quarter/Year ended 31st March 2023. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2023 and the Statement of Profits and Loss and Cash flow statement of change in equity and notes thereon for the year ended 31st March 2023. Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow Statement and Auditors' Report thereon by Statutory Auditors for the Quarter/Year ended on 31st March, 2023, in PDF Format, which were also approved by the Audit Committee and Board of Directors at their meeting held on Tuesday, 30th day of May, 2023 at 3:00 P.M. and the Board meeting was concluded at 7:30 P.M. Since, the Auditor's Report is self-explanatory and has no modification/qualification, it needs no further comments by the Company. We are also in process to file the aforesaid financial results in XBRL format within the stipulated time and same shall also be hosted at the website of the company www.natrajproteins.com. The Financial Results will also be published in widely circulated English and Hindi (Vernacular) newspaper in the prescribed format for that purpose. (As Per BSE Announcement dated on 30.05.2023)
25-Jan-2023	13-Feb-2023	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. Approval of the Standalone Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2022. 2. To take on Record the Limited Review Report by the Auditors for the Standalone Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2022. 3. Other Regular matters. This is in continuation of our letter no. NPL/SE/2023 dated 25.01.2023 regarding intimation of Board meeting for consideration and approval of the Quarterly/Nine Monthly Standalone Un-Audited Financial Results & Limited Review Report thereon, for the Quarter/Nine Months ended 31.12.2022. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015 we are pleased to submit the following; (a) Standalone Unaudited Financial Results for the Quarter/Nine Months ended 31.12.2022; and (b) Limited Review Report by the Auditors for the quarter ended 31.12.2022, Which was considered and approved by the Board at their 05/2022-23 Meeting held on Monday, the 13.02.2023 at 3:00 P.M. The Financial Results will also be published in widely circulated English and Hindi (Vernacular) newspaper in the prescribed format for that purpose. We are also in process of filing the aforesaid financial results in the XBRL format within the stipulated time and same shall be hosted on the Website of the Company. (As Per BSE Announcement Dated on 13/02/2023) Submission of Press Clipping Related to extract of Standalone Un-Audited Quarterly and Nine Monthly Financial Results for the Quarter and Nine Months ended on 31st December, 2022. This is with reference to the above captioned subject, regarding Additional details required by the email dated 14.02.2023 at 3:43 P.M. as required under SEBI Circular dated September 09, 2015, for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015 with respect to the Submission of the Standalone Un-Audited Financial Results & Limited Review Report for the Quarter/Nine Months ended 31.12.2022 u/r 33 of the SEBI (LODR) Regulations, 2015 observed by the BSE that 'Board Meeting Concluded Time not Given'. It may please be considered that the said Board Meeting was concluded at 4:45 P.M. on 13.02.2023 and the time of meeting conclusion was also disclosed while filing of results in the XBRL at the portal of BSE. This may be considered as compliance as required under Regulation 30 of the SEBI (LODR) Regulation as required under in the Para No. 4 of the Annexure of the Circular No. CIR/CFD/CMD/4/2015 dated 09.09.2015. (As Per BSE Announcement dated on 15.02.2023)
02-Nov-2022	11-Nov-2022	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve 1. Approval of the Standalone Un-Audited Financial Results of the Company for the Half year/ Quarter ended 30th September 2022. 2. To take on Record the Limited Review Report by the Auditors for the Standalone Financial Results of the Company for the Half year/ Quarter ended 30th September 2022. 3. Approval of the Standalone Un-Audited Statement of Assets and Liabilities for the half year ended on 30th September 2022; and 4. Approval of the Standalone Un-Audited Statement of Cash Flow for the half year ended on 30th September 2022. Approval for appointment of Mr. Abhinandan Prajapati as the Chief Financial Officer of the company w.e.f. 11.11.2022 (As Per BSE Announcement dated on 11.11.2022)
13-Aug-2022	22-Aug-2022	AGM	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2022 inter alia to consider and approve 1. Approval of the Book Closure for the purpose of the 31st Annual General Meeting. 2. Approval of the cut-off date for eligibility to participate in the remote E-voting etc. 3. Approval of the Boards Report and Notice of the 31st Annual General Meeting. 4. To Appoint Scrutinizer for the process of remote E-voting as well as e-voting at the AGM. 5. Appointment of Statutory Auditors for a term of 5 years in place of retiring Auditor M/s Anup Shrivastava & Associates Chartered Accountant of the Company. 1.Finalization of the Annual Book Closure of the Company for the 31st Annual General Meeting to be held on 24th September, 2022 at the Registered Office of the Company situated at Nagpur Kalan, Ordinance Factory Road, Itarsi (M.P.) 461111; 2.Finalization of the Cut-off Date and Remote E-voting period for the Ensuing AGM; 3.Approval of the appointment of Scrutinizer for the E-voting process 4.Recommend the appointment of M/s Bhutoria Ganesan & Co., Chartered Accountant (FRN: 004465C) as the Statutory Auditors for a First term of 5 years in place of retiring Auditor M/s Anup Shrivastava & Associates, Chartered Accountant; 5.Approval of the Boards' Report, Corporate Governance Report and Notice of the 31st Annual General Meeting; You are requested to kindly take the same on record for your further needful. As per requirement of Section 139 of the Companies Act, 2013 and the Rules made there under, it is mandatory for Company to rotate the existing Statutory Auditors, M/s Anup Shrivastava & Associates, (Firm Registration No. 006455C) on completion of the maximum term of five years permitted under the said Section and they need to be retired at the forth coming annual general meeting scheduled on 24th Sept., 2022. Therefore, the Audit Committee of the Company has proposed and the Board of Directors of the Company have recommended the appointment of M/s. Bhutoria Ganesan & Co., Chartered Accountants (Firm Registration No. 004465C) as the statutory auditors of the Company for a term of five years, subject to the approval of shareholders of the Company at the ensuing annual general meeting. We hereby submit the following disclosures as required under regulation 30 of the SEBI (LODR) Regulations, 2015 and circular issued for compliances by the SEBI. (As Per BSE Announcement Dated on 22.08.2022)
01-Aug-2022	08-Aug-2022	Quarterly Results	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 inter alia to consider and approve 1. Approval of the Un-Audited Quarterly Financial Results of the Company for the quarter ended 30th June 2022. 2. To take on record the Limited Review Report by the Auditors for the Financial Results of the Company for the quarter ended 30th June 2022. 3. Other Routine Businesses. This is in continuation of our letter no. NPL/SE/2022 dated 01.08.2022 regarding intimation of Board meeting for consideration and approval of the Quarterly Standalone Un-Audited Financial Results & Limited Review Report thereon, for the Quarter ended 30.06.2022. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015 we are pleased to submit the Unaudited Financial Results and Limited Review Report by the Auditors for the quarter ended 30.06.2022, in PDF Format, which were also approved by the Audit Committee and Board of Directors at their 02/2022-23 meeting held on Monday, 08.08.2022. The Financial Results will also be published in widely circulated English and Hindi (Vernacular) newspapers in the prescribed format for that purpose. We are also in process of filing the aforesaid financial results in the XBRL format within the stipulated time and the same shall be hosted on the Website of the Company. (As Per BSE Announcement Dated on 08/08/2022) Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(b) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone Unaudited Quarterly Financial Results for the Quarter ended on 30th June, 2022 which was approved in 02/2022-23 Meeting of the Board of Directors held on Monday, 8th August, 2022 at 3:00 P.M. at the Registered Office of the Company. We herewith enclose the newspaper advertisement published on 09.08.2022 in Free Press Journal English edition and Chotha Sansar Hindi edition. You are requested to please take on record our above said information for your reference and record. (As Per BSE Announcement dated on 10.08.2022)
18-May-2022	30-May-2022	Accounts	NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve 1. To consider & approve the Standalone Audited financial results of the Company for the Quarter/Year ended 31st March 2022. 2. To take on record the Audit Report of the Statutory Auditors for the Standalone Audited Financial Results of the Company for the Quarter/Year ended 31st March 2022. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2022 and the Statement of Profits and Loss and Cash flow statement of change in equity and notes thereon for the year ended 31st March 2022. Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Audited Financial Results along with Auditors' Report thereon by Statutory Auditors for the Quarter/Year ended on 31st March, 2022, in PDF Format, which were also approved by the Audit Committee and Board of Directors at their meeting held on 30th day of May, 2022. (As Per BSE Announcement Dated on 30/05/2022)

1 2

LOGIN HERE

Natraj Proteins Ltd

Board Meeting